Search
Elias Zerhouni and Andy Plump discuss the future of multispecific biologics
Interviewed by Andy Plump, President of R&D at Takeda, Dr. Zerhouni discusses the rationale for multispecifics and the science behind...
Apr 7
From Japan, Takeda's CEO Christophe Weber talks about the company's Japanese roots, but global transformation - plus, five key pipeline assets
He describes Takeda's HQ and R&D facilities in Japan, but also how global markets have grown to dominate the company's business since he...
Nov 18, 2024
Christophe Weber describes Takeda's global perspective on R&D and business development
Takeda's CEO talks about the $4B+ Nimbus acquisition, recent approvals, and what's ahead for the company in 2024.
Jan 8, 2024
.png){kind=logo}
